METTL3 and Alzheimer disease: The results showed that compared with those of non-AD patients, the aortas of TAAD patients had higher METTL3 protein levels (Figure 3E, 3F and Supplemental Figure S4), indicating a vital role of METTL3 in the pathological processes of TAAD.